Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Current Rheumatology Reports|April 5, 2001
Helicobacter pylori and NSAID gastropathy: an ambiguous associationA M Fendrick, J M Scheiman
The American Journal of Gastroenterology|July 27, 2001
Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsiaU Ladabaum, A M Fendrick, J M Scheiman
Alimentary Pharmacology & Therapeutics|May 28, 2011
Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary preventionS D Saini, A M Fendrick, J M Scheiman
The American Journal of Gastroenterology|October 15, 1998
Identification of patients with resectable pancreatic cancer: at what stage are we?A B Gorelick, J M Scheiman, A M Fendrick
The American Journal of Gastroenterology|March 10, 2000
Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease?M Rich, J M Scheiman, W Tierney, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysisU Ladabaum, W D Chey, J M Scheiman, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysisJ M Scheiman, R R Bandekar, M E Chernew, et al.
The American Journal of Gastroenterology|August 5, 2000
The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreasW M Tierney, A M Fendrick, R A Hirth, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2008
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providersN Elnachef, J M Scheiman, A M Fendrick, et al.
Annals of Internal Medicine|November 6, 2001
Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysisU Ladabaum, C L Chopra, G Huang, et al.
Pageof 15